Neuland Laboratories Ltd.
NEULANDLAB (NSE)

1,185.55

1,521.05
Proj. ROE (%)
9.50
Proj. P/E (x)
-
Proj EV / EBITDA (x)
8.90
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
1,082.87

Stock View

HOLD
Share on
The average score for Neuland Laboratories Ltd. stands at 5 against 6, three months back.

Neuland Laboratories Limited is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The company is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The Company operates through manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The Company has 3 manufacturing facilities and one R&D facility in Hyderabad.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,123.72
100 DMA ()
1,150.35
200 DMA ()
1,382.36
52 Weeks Range
967.00
2,273.15
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity